Anesiva's media center is designed to provide reporters with easy access to news about the company and its products for stories in development. If you don't find what you are looking for or need more information, please contact us.
| All Releases |
|---|
 |
Anesiva and Lumen Therapeutics Enter Agreement Granting Lumen Access to Data From Studies in Bypass Procedures
Nov 30, 2006
|
14.6 KB
|
| |
SOUTH SAN FRANCISCO, Calif. and MOUNTAIN VIEW, Calif., Nov 30, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Anesiva, Inc. and Lumen Therapeutics announced today that they have entered into an agreement which grants Lumen a non-exclusive license to clinical data and technical information relating to the prevention of saphenous vein graft d...
|
|
|
Anesiva Announces Filing of New Drug Application for Zingo(TM) to Reduce Pain Associated with Needle Insertion Procedures in Children
Nov 27, 2006
|
11.6 KB
|
| |
SOUTH SAN FRANCISCO, Calif., Nov 27, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Anesiva, Inc. (Nasdaq: ANSV) announced today that the company has filed a New Drug Application (NDA) with the FDA for marketing clearance of Zingo(TM) to treat the pain associated with venous access procedures in children. As part of the company's continued ...
|
|
|
Anesiva to Raise Approximately $45 Million in Registered Direct Common Stock Offering
Nov 22, 2006
|
11.0 KB
|
| |
SOUTH SAN FRANCISCO, Calif., Nov 22, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Anesiva, Inc. (Nasdaq: ANSV), a biopharmaceutical company, focused on the development of novel pain therapeutics, announced today that it has obtained commitments from selected institutional investors to purchase approximately $45 million of its common stock...
|
|
|
Anesiva to Present at Lazard Capital Markets Annual Life Sciences Conference and Piper Jaffray & Co. Annual Health Care Conference
Nov 20, 2006
|
10.1 KB
|
| |
SOUTH SAN FRANCISCO, Calif., Nov 20, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Anesiva, Inc. (Nasdaq: ANSV) announced today that John P. McLaughlin, the company's chief executive officer, will present at the Lazard Capital Markets Annual Life Sciences Conference in New York City on November 28, 2006 at 1:00 p.m. EST.
Mr. McLaughlin...
|
|
|
Anesiva Announces Third Quarter 2006 Financial Results
Nov 9, 2006
|
15.9 KB
|
| |
SOUTH SAN FRANCISCO, Calif., Nov 09, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Anesiva, Inc. (Nasdaq: ANSV) today reported financial results for the third quarter and nine months ended September 30, 2006.
"We are on the verge of achieving a significant milestone for Anesiva in that, this month, we will be filing a CTD / NDA (Common...
|
|
|
Click here to download our most recent fact sheet.